INS and pancreatic insulinoma: Song et al. [47] reported that the overexpression of iPLA2β enhances insulin secretion by activating p38 MAPK in INS-1 insulinoma cells and isolated islets, and pharmacological inhibition of p38 MAPK prevents this effect.